Roche to launch global study of Elevidys following EU rejection
Roche will launch a global Phase III trial of its Duchenne muscular dystrophy (DMD) gene therapy Elevidys (delandistrogene moxeparvovec), after…
News
Acerand reports first-in-human trial results for ACE-106 therapy
First patient receives JANX014 dose in Janux’s trial for mCRPC
Developers back Alzheimer’s drugs despite report suggesting lack of efficacy
Lilly debuts more Foundayo data as FDA requests post-marketing trials
Storm clinches $56m in Series C for Phase II on lead sarcoma drug
TG Therapeutics concludes enrolment in Phase III Briumvi trial
Precision receives CTA approval to expand ELIMINATE-B study
